In this week’s episode, Grace and Liel do a reality check on the benefits and shortcomings of ChatGPT, from how it can improve your process and client experience at your law firm to where it should be used with caution to avoid damaging your reputation.
As we settle in 2023, Grace walks us through some of the latest updates in the Tylenol Mass Tort, also known as the “Acetaminophen Lawsuit.” Grace also discusses the details of an emerging class action that primarily affects women who use hair-relaxing products.
Join our conversation and hear what happens when you put ChatGPT-3 on the bench, why 2023 is having a solid start on the Mass Torts front, and also get a sneak peek of what is taking place this week in Miami during Trial Lawyers Summit.
Resources mentioned in our episode:
- Mass tort launched for claims that acetaminophen caused autism
- Chemicals in Hair Straightening Products
- 2023 National Trial Lawyers Summit in Miami
Enjoy the show? Subscribe and leave us a review! Don’t forget to send us your questions and comments at ask@incamerapodcast.com.
Transcript
Liel: [00:00:00] Gpt is the language model developed by Openai that uses machine learning to understand and generate human like text. It is widely used in natural language processing and chat bot development to create more human like conversations and automate tasks such as content creation. Gpt three is the third version of the model, which is considered as the most advanced AI model in text generation. I’m Liel Levy, co-founder of Nanato Media and author of Beyond Se Habla Español How Lawyers Win the Hispanic Market. And this is in Camera podcast where we let short GPT write our episode intro. Welcome to in camera podcast, Private Legal Marketing Conversations. Grace. Welcome back. I missed you.
Grace: [00:01:13] I missed you, too, Liel. It’s been a minute.
Liel: [00:01:15] Yes, it’s been a little bit too long. And I’m so excited that we’re here that we’re ready to start our first official 2023 conversation. And oh, boy, there is so much to talk about, right? Starting off by the fact that this episode is coming out the week that National Trial Lawyers Summit is taking place in Miami. So that’s so exciting. Right. And hopefully we’re going to have some things to share about that on our next episode. But yeah, I’m just I just so excited to hear about all of the things that you guys have planned out. And so if you’re listening to this on your way to the trial or your summit, know that you should definitely stop by the first booth because there’s going to be some exciting things, exciting stuff happening there. Why not give us a quick sneak peek? Grace.
Grace: [00:01:59] Sure. Thanks, Liel. So the highlights are we’re going to have Mike Tyson as our meet and greet celebrity. So for many of you who know, right, I’m I’m very excited. But yeah, he’s he’s pretty cool. Like, for those of you that know us as the league law firm and persist group, we’re persistent in the pursuit of justice for everybody. So part of our branding and our ideas, right? I mean, that’s for us. That’s what it is about. That’s why we when we first started this whole celebrity thing for NTL, we started with Danica Patrick, who can be more persistent than a female in Indy. You know what I mean? Like a race car driver, female. Amazing. Then John McEnroe. Now here we are, third year running. We’re going to have Mike Tyson.
Liel: [00:02:44] That’s amazing. Grace Honestly, I’m very, very, very inspired by everything that you guys have done in terms of really bringing entertainers, sports persons, personalities into the event. Everything that you do from the events that are inside as part of the conference to everything that happens outside, and that is on top of just being a very prominent exhibitor at the conference. So that’s exciting. And we are very, very much looking forward. At least me and my team are very much looking forward to experiencing this. And yeah, for those of you who are going to be around there, stop by the national media booth. We’re going to have fun things happening. We’re also going to have our mini little day of presentations so you can get more information in there, learn a little bit more about sonic branding, and learn a little bit more about the Hispanic market and why you should certainly be tapping into that opportunity and hopefully just have a great time there, right?
Grace: [00:03:40] Definitely. And you’re underselling what you’re talking about. So, ladies and gentlemen, please pay attention here. He’s talking about an event he’s going to have across the street on Wednesday. So this is going to go out on Monday. You’ll be able to hear this and then actually join it when he’s talking about sonic branding and all of those things. This is something that most of you have not heard of or have heard of, but very, very briefly. So please, please, please. This is going to be a great presentation. Make sure you go and you go visit Nanato media’s booth and see what it’s all about.
Liel: [00:04:13] All right. Thank you so much, Grace. You’re making me blush here. All right, enough about self promotion. Now, let’s get into the conversation of today, because it’s going to feel for a lot of you that both Grace and I are jumping late into the bandwagon of Chad GPT. So Grace. Let’s let’s start from the very, very beginning because I wouldn’t be surprised that a lot of people are hearing Chat GPT and have no clue what that is about. So break it down and make it easy for those who are still lost when it comes down to that conversation.
Grace: [00:04:50] So I Liel’s asking me to do this because I’m very good at the layman term part of things when it comes to software. So to make it as simple, literally as simple as possible, this conversational chat bots that you interact with on all kinds of websites, this is a component of that. However, it takes it a step further. It calls it chat bot AI. And when everybody talks about AI, that’s artificial intelligence. What that really truly means is that you’re feeding data information to the chat bot so that it naturally responds to questions and it acts like it’s a person. That is what this AI, this chat bot. And when we’re talking about that, that’s what we’re talking about is a bot that can act like close to a human and answer questions that are naturally requested the way you and I speak and then answers in the way you and I speak. Not the usual. How are you today? Click button. Yes, click button. No type of thing. No. This is natural language requests for information and natural language requests besides the information responses.
Liel: [00:05:58] Yeah, that’s it. It’s basically more powerful A.I. system that what it can do now, particularly talking about chat. Gpt Is it able to basically create content based on questions, instructions, fact checking, things that are presented to it? And obviously right now there is a lot of hype going on around it. But what is very important for us to understand is that this technology did not emerge all from the southern and it’s been around already for a while and it’s been put in use for many different things. But one that’s been very prevalent and known is content writing, right? Why do I need to write my own content if I can just get a machine to do it for me? Right, I will tell it. I need you to write an article about how to apply for the best credit card bonuses in the year of 2023. And you go out and you put up that inquiry and the bot is going to generate a content for you. Now, here’s the thing. The thing now is that with chat GPT, things gotten better, right? The I bought like Grace was calling it, it’s now smarter. Now the quality of content and the complexity of commands has increased and what’s happening now. And I think the battle where this conversation becomes relevant for us is do we need to fear that chat GPT is going to, in a way or another, replace the valuable content that law firms who are creating blog articles and practice area pages is going to be impacted.
Liel: [00:07:46] If you are doing a complex and robust SEO strategy and now all of a sudden you have a bunch of other law firms that are going to start putting chat. Gpt Bot generated content on the website at a much faster rate and probably you are in such. How is that going to affect your firm or not? So I think that’s kind of like where these things can go from the marketing standpoint because that’s what we do here. We talk about legal marketing now. I mean, from a practical, practical and convenient side business of law, sort of things like managing your internal operations, this is a wonderful technology that should be embraced. I don’t know how much we can rely on it for it to really complete tasks, either do complete tasks or tasks without supervision. But I certainly think that we’re going to be able to continue leveraging a lot of opportunities coming out from this type of technology in order to just become more efficient. Efficient, right, especially through automation. Grace, what are your thoughts? Let’s let’s cover that part, the business of low side of things. Then we can go and wrap it up on the marketing side of things. Yes.
Grace: [00:08:54] So on the business of loss side of things, 100%, I agree with you. It’s one of those things that can be used, but it will always need to be supervised. It’s they tell you right on the on the site, as a matter of fact, that this is the fourth version of it that they are releasing and that while it’s darn good and it can even code now for you and build code, it still needs supervision, but it gives you a base to work off of. And that’s what I use it for, is to have a base model to work off of. So it gives me kind of like the basic structure and terms that I want and it gives me an idea of what I’m looking for and what the good words and all that kind of stuff. However, I always need a content person to look it over, review it, and then I further review it for accuracy and legalese.
Liel: [00:09:44] So yeah, 100% it does need a lot of supervision now, but what you’re bringing up here is that number three, which is the current version and heading towards number four, it already feels that it’s going to be much smarter. Right. And so people are talking about that. They’re saying like, yeah, the one now, it’s impressive. But really what I’m interested or what worries me is what’s going to happen when when three or four or five versions from now start coming up. And as you’re saying, Grace, I think ultimately also as humans were going to be very well at understanding where we can leverage content or where we can leverage work that is produced by an automated machine or in when is it that we need to step in. And what I do like about just generally speaking, about all of this technology that becomes available to us is that it can certainly help us become more efficient without necessarily having to having to get us out of the things that we like to do. That’s that’s where I see that it can be very, very valuable no matter what your line of work is. If you can find a way where transactional in simple and small things that you anyhow did not necessarily enjoy doing, completing or performing can now be done by a machine, then I think that’s wonderful.
Liel: [00:10:56] That’s a great opportunity that. Needs to be embraced. And that’s a great way to becoming more effective. Right. So as a whole, I think, you know, thumbs up to the technology. But now, if we may, let’s talk a little bit from the marketing standpoint. So do we feel that search engines are going to be empathetic towards bot generated content? I mean, Grace, my my, even though there is good things that come out of these machines, I personally believe everything still needs to be line edited. And it’s editorial work. And the thing about it is that it’s not accurate. It’s not accurate at all. It writes and collects and pulls information that may be. About accurate, but it’s not precise. And so particularly when you were talking about the legal industry, everything needs to be factual. Everything needs to be factual. And if it’s not, then you need to also be very precise at determining what are the things that not and why. And for that one reason, I believe that it’s not going to necessarily be very, very helpful from really coming up with content that’s going to be helpful to the users.
Liel: [00:12:20] And that’s what we need to always keep in mind. Right, Google. So let’s put it that way, right? Is GPT the new content form? Probably it is. And we already know Google doesn’t like content forms. They don’t like them, you don’t like them. So there is no indication that tells us here that it is now all from the sudden going to become more acceptable to search engines. And ultimately the other thing that needs to be taken into consideration is that it’s, you know, the same tech that is powering GPT. It’s going to get to the search engines as well. And they’re going to be able to to tell to understand what’s actually being written by a human and what isn’t. So I think, you know, as as excited as we want to get about, hey, you know, I’m going to go and fire everyone in my team that that deals with content creation, marketing and such because right now I can get a lot of that through chat GPT. I think you’re still putting at stake a lot, obviously, number one, your brand and reputation. And number two, the results that you are generating through more carefully curated content. Grace. Go on please, because I’m here on a monologue.
Grace: [00:13:30] My main concern and I know that exactly what you’re saying about content on Google, right? Google has semantic algorithms and real people looking at the information that comes through it. So even Google has people right as part of their AI and they say it, they tell you all the time they have people reviewing the semantic language and making sure things are being fed back in data wise. So, yeah, Google is going to see that. Google is going to know it’s a spin rewritten and know that it’s going to be potentially duplicate content even if it’s not all pulled from the same source. This is still could be considered majority duplicate content because you’re taking content from other places and putting it in one place. So without editorial review, without, you know, line item editing, this is not going to work the way even close to the way you believe it should.
Liel: [00:14:19] There is no source’s Grace. You don’t know where the information is coming from. And that’s why even when when the idea that will why do I why, why would I need Google anymore if I can just go and get Chat GPT to give me all the answers they need because you cannot fact check them. You don’t know where this information is coming from, right?
Grace: [00:14:39] Exactly. Exactly. Yeah. Sources were legal. This is the legal industry. We need sources and it has to be accurate, not just accurate. It needs to be legally factually correct. So, yeah, no, I completely agree with you that this is a good tool. It is not the be all and end all and it will not replace anything that you’re doing currently, no matter how you want to look at it. I’m telling you, this is not going to replace anything.
Liel: [00:15:05] Right. And you know what? And the things that it will, great, because it’s going to be to your benefit. And there are things that maybe maybe they don’t necessarily need a human to be taking care of. But certainly when you’re dealing with human relations, you probably want to keep the humans at least of those things. I know. That’s why my common sense says, Right. All right, Grace. So that’s Chad. We’ll just be looking at it. I mean, it’s really, really impressive. I don’t know if you’ve been paying a lot of attention to the news, but the offer that Microsoft. Well, it’s kind of like an agreement that Microsoft and Openai are putting in as a way of kind of like merging, partnering together. It’s really, really mind blowing, like all of the different elements of the partnership. They’re buying it, but not necessarily buying it, but they’re going to be taking the majority of the revenue of the profits, but up to a certain extent, and they’re capped. And the bottom line is that this company is being now valued at $100 Billion. And that’s like, wow, a very, very aggressive valuation for something that, you know, is still kind of like where it is. So we’ll see. But certainly something that needs to be on everyone’s radar. All right. Other things that need to be on our radar master’s updates. It’s already a new year 2023. I’m sure we want to hear about some of the ones that we’ve been following for the past few months. But there’s also new stuff. So, Grace, why don’t you walk us through some of the updates there?
Grace: [00:16:32] Certainly. So I wanted to start originally with the hair relaxer stuff. However, I do want to mention the updates on the Tylenol. So the criteria has updated. I know I very briefly mentioned that last year when we were. Talking about some mass torts and the Tylenol. They believe it causes autism and or ADHD, behavioral issues in children when pregnant women are taking it while they’re pregnant. So with that being said, the criteria has slightly been modified. Prior it was you had to take it X number of times, but they also have included some additional products. So it’s not just Tylenol. It’s like anything with acetaminophen that’s been produced or manufactured, excuse me, by Johnson and Johnson. And those are like Alka-Seltzer plus. I mean, these are things that people take just on the regular. So it’s a little crazy, right?
Liel: [00:17:31] Yeah. Yeah. You go and buy it. Yeah, no problem.
Grace: [00:17:33] Yeah. Dayquil Excedrin flu therapy might all Mucinex. I mean, these are things that are like. I mean, when you’re pregnant, it pretty much you believe in the back. It tells you, you know, ask your doctor and all of that, but that they’re fairly safe. Or at least that was the idea. So they’ve opened it up to other syndromes, which are all behavioral related as well. Besides the autism spectrum disorder, they’re specifying Asperger’s syndrome, Kanner syndrome, childhood disintegrated disorder. So literally your child is falling apart. It’s awful pervasive developmental disorder and then ADHD, which is specific. Huh? Yeah. So there’s a few things. There are some excluding factors, as they call them. So basically, if you had, you know, if your child was diagnosed with Down syndrome, Fragile X, Tourette’s or tuberous sclerosis, it unfortunately disqualifies your child from this case. If they were taking certain other types of drugs over certain ages, you know, basically things that could affect the litigation. Right. And that show, hey, you know, other identifying factors could be involved. And it can’t be linked necessarily to the acetaminophen. So just like anything else, guys, you know, you know that this is always emerging litigations and they’re always changing the criteria based on what they find during the science days or the days or the information that’s coming out in memos or advertising or marketing. So that’s Tylenol. Do you have any questions about the Tylenol criteria and kind of what’s been happening?
Liel: [00:19:16] So are we now looking at a more stable mass tort here? Is it is it at a stage where it’s already like our case is getting signed?
Grace: [00:19:26] They’re getting signed and they’re being filed very, very soon. So, yes, we’re definitely at that stage where it’s past emerging and it’s now in its, I would say, infancy, but it’s definitely out there and people are signing up and they’re, you know, we’re going to see how this all shakes out in the next month or two.
Liel: [00:19:45] Yes. Please keep us up to date on that one.
Grace: [00:19:47] Definitely. So this one, it’s kind of a big deal. This next one that I’m going to tell everybody about, it’s an emerging mass tort and it’s on chemical hair relaxers. Now, the history of chemical hair relaxers is is pretty extensive. I don’t know if anybody actually was on the I believe it was. I’m not sure if it was Harris Martin or if it was AMP that put it on. But basically they had a hair relaxer webinar and they went over the history and kind of what’s going on with the science behind the hair relaxer talk. So what’s been happening is it’s primarily African American women that use hair relaxers and the hair relaxers, what they do is they use a chemical that’s in the hair relaxer to release the curls in the person’s hair. And the way it releases those curls is that the chemicals make the proteins less strong. It basically breaks the proteins in the hair to release the.
Grace: [00:20:48] Coils.
Grace: [00:20:48] In a person’s hair. And because most hair is protein, it’s keratin, protein and some other lipids and things of that nature. The science side of it, right? So in order to release it, they used to use lye, which is like soap back old school soap and, and other components to release the coil. Now, Johnson and Johnson came out with a safer version because they found that lye was causing skin like severe skin issues in people and that long term, your hair would fall out because over time you’re weakening it constantly. And if you use it too often, your hair could fall out. So when they came out with this better and less, more safe solution, that was quite a few years after they’d already started using these lye based products. Now. After that. What ended up happening is they realize that people seem to be women who are using these seem to be much more likely to develop certain diseases and or cancers. Now, this is extremely new, right? And when I say this is an emerging litigation, that’s why I’m seeing emerging litigation. And it’s because they still need a lot of the science days that I talk about when something first comes out. And that way they can make that link, right? So for those of you who aren’t attorneys and are listening to this as a marketing person, it’s always about the link between the tort and the injury.
Grace: [00:22:24] Can we prove that this caused that or at least darn close? That’s when I talked to you guys many, many seasons ago about Daubert or Frye. So basically, it’s a bellwether trial that has to happen in most cases to make sure that they can link everything right. They say this this hair relaxer product can and will potentially can and will cause these cancers or these issues. We’re not there yet. So right now we’re in the findings phase. And what they have found thus far is that they believe it is causing one moment uterine cancer, ovarian cancer. Endometriosis, uterine fibroids, and or potentially breast cancer. So as of right now, two, three, four, five, those are the five diseases or injuries that they believe the hair relaxers are causing in women. Now, the requirement is that they have used hair relaxers at least four times in a year. That is so far the current criteria. It might change, as you all know, depending on what they find out. But I’d say most African American women tend to use the hair relaxers once their hair starts growing out again so they can and do generally use it for two plus times a year if that’s part of the regular hair regimen. So the possibility for this affecting a lot of women, it’s it’s pretty massive, honestly. It’s this is this is part of like a.
Liel: [00:24:06] Lot of part of my ignorance. But like, why would you use a hair relaxer? And I’m asking this as someone who’s not necessarily familiar with the product, like, is this something you apply at your home? Do you go to a salon for a treatment like so?
Grace: [00:24:22] This one is specifying about the ones you apply at home, right? So you can go buy a box, like you can go buy a box of hair coloring, right. As an example, it’s the same concept. You buy a hair relaxer instead of coloring your hair. What you’re doing is you’re relaxing your hair and relaxer. All it is doing is straightening your hair. So it’s a hair straightener.
Liel: [00:24:41] It’s a.
Grace: [00:24:41] Chemical. Hair straightener is what it is.
Liel: [00:24:44] Okay. All right. Wow. So this is terrible. I mean.
Grace: [00:24:51] There’s some women there every month that used a new box every month. I mean, think about hair coloring, because this is very similar to that. If your hair grows out and you have a half inch of the wrong color. It’s the same thing with this. If your hair grows out and you have a half inch of curly hair and the rest of your hair straight, you’re going to use it again.
Liel: [00:25:10] Yeah. So what you’re saying, Grace, is that the products are not products that are discontinued. They’re still on stores, they’re still being sold and they’re still potentially generating harm. So this has that potential. And so do we think that the next step is waiting for a recall or can the mass tort start before there is a voluntary recall by by all of those who are using these chemicals in their products?
Grace: [00:25:40] They can start before there’s a recall. We’ve already started looking for cases. So, yeah, for us, it’s we’ve already began the outreach to let people know about this because it’s going to affect so many people. And some of the potential plaintiffs, the way they look at it is hairstylists and beauticians, because they do buy L’Oreal and some all of these products that are hair relaxers that they apply to their their people. Right. And generally even absorb it in their skin. And if they use it right, I mean, a lot of women that are beauticians or hair stylists use the products that they apply to other people to.
Liel: [00:26:14] Right.
Grace: [00:26:15] And then, of course, long term users of hair relaxers like to answer your question, yes, you can go into a store, Walgreens even, and wherever and buy a box of hair relaxer and apply it to your head.
Liel: [00:26:25] Yeah, that’s how it was sounding to me for the most of it. So by the looks of it, Grace and please correct me if I’m wrong, this sounds like it’s going to be a long sit and wait despite all of the research that’s being done. Because there it’s going to take some time, right, to for a consensus to emerge where. It is very, very evident that there is a correlation between the usage of this and that in the in the public eye. I’m assuming I’m not. Obviously, the legal space seems already very, very convinced.
Grace: [00:27:02] Yes. And there’s enough information out there so far that they believe that this is strong enough to continue forward. And generally speaking, if its strong enough to continue forward, they’re going to. My personal experience with Torts over the last eight years, I don’t I do believe that they were going to drop some of these diagnoses. Mainly, I personally believe breast cancer is going to be dropped from this because many of you may or may not remember talcum powder had breast cancer on there as well. And that was one of those diagnoses that was a little loose. Right. So I believe that this is going to change pretty quickly, quickly in the scheme of things, Right. When I say quickly. But yes, it’s so new, it’s emerging and this is going to change. It’s quite a few things of this are going to change. And as I find out about it, I will definitely let you guys know because we’ll be getting cases in and we’ll see what the makeup of the people that are affected look like. Right. And how many times they have uterine cancer or ovarian or endometriosis. And we’re going to see what the census looks like. And at that point, we’ll we’ll have a lot more information as to how many people are affected and what we’re seeing in terms of injuries.
Liel: [00:28:20] Yeah. Well, Grace, thanks so much for keeping us posted on that and helping us keep the polls of mass torts, because obviously it’s an ever changing thing. And, you know, it’s there’s just ones that are evolving and then all there’s ones that are coming on as new. So I think, you know, the Tylenol one was kind of like an underdog from what I recall the last year. A lot of them be witty around it, but it seems like it’s starting to get consolidated into something. And these obviously, it’s it’s super early days from what it sounds, even though, you know, I appreciate you and your team take a very proactive approach towards starting your outreach efforts early on. But it will be very interesting to see what these things potential mass torts evolve into. So, Grace, I think, you know, we went through a few things today and enough for us to get us some good takeaway. So why don’t we start there? What’s your first takeaway?
Grace: [00:29:24] You know, it has to be with the Cat Eye and GPT. Yeah, you know, just don’t don’t forget that a pair of human eyes, particularly good quality editors are always going to need to look at your content. You cannot rely solely on automation. And at least not for the near future. Maybe never ever, but definitely not for the near future. Chat Gpt has not. Has been out forever. It is getting better. Use it as a tool, not as your replacement. That’s my first takeaway.
Liel: [00:29:59] Yeah. You know how to not be completely. Negative about it on the creative side of things. Use it as a as a baseline, Right? Use it as a way of getting inspired, getting ideas, getting some feedback into some thoughts that you have. I think that’s wonderful. I just wouldn’t necessarily treat it as a finished product just from what it basically generates from you, from the screen, and then just publishing that as if it was done. And hopefully a lot of you are not doing that anyhow. So Grace, I’m going to make take away number two about our amazing conference. You know, I’m so excited about it. Grace And you know, there’s a lot going on. It’s a fun conference. It has obviously the conference part of it. But there also there’s all the other events surrounding it. Like you like you were saying, your big bowl party on Monday night. And then obviously there is the Golden Gavel Awards, which are always interesting because of the recognition that legal law firms and advertisers alike paid for their campaigns. You know, we were nominated for three categories. Yeah, we’re actually very, very excited about it as well. Yeah. And yeah, so, you know, if you’ve never been to one, you should definitely consider maybe it’s too late to go to this one, but go to one of the other things that the trial lawyers do because they actually put very good events, to be quite honest, like having been to a lot of them. And I think there is are amongst the best I know. What are your.
Grace: [00:31:33] Thoughts? No, I agree. I think that the events that they put on are clean, you know, And yeah, the information just makes sense when you go, Yeah, yeah. We go to so many conferences and events that I think we can tell by now what’s a good one versus a bad one, you know, and I don’t think any of them are bad necessarily, or at least not that I’ve attended. I attended one really bad one, but other than that, I can’t say any bad ones. They all give some sort of value, just some give more value than others. And I agree with you, it’s more value than some of the others do.
Liel: [00:32:04] Yeah. Yeah. Listen, I was yeah. You know, obviously as an as an exhibit or here I my mind is thinking of other things but I’ve actually sat down in a lot of the of the presentations and talks and they’re in there. The content is terrific. It’s really, really mind blowing. And I’m not a lawyer and I sometimes go and sit up on the on the trial talks like I had the privilege of listening to Ben Crump and Mark O’Mara last year. And it was just like, yeah, tremendous. Very, very, very good. Yeah. Excellent. So we have that and then we have a final takeaway for a day, right? And I believe we need to wrap up with mass torts.
Grace: [00:32:44] Yep, I agree. So, you know, a little bit of a reminder, I guess when it’s an emerging litigation, there’s obviously a lot more stuff that needs to go into it. But it is a good time to get into the organic side of marketing for a mass tort. So if you’re aware of it, if it’s something that makes sense to you because you know, whatever the reason, you know, if you believe in the cause or it just makes sense and something that you can handle, I say put up a practice area page and do some minimal. It doesn’t have to be extreme. You can even use Chat GPT to help as a tool. But I would say put it out there. If it’s something that makes sense for you to do for Tylenol and or hair relaxers, because I think it’s going to affect so many, so many people. And if it’s a cause that makes sense to you, start gathering these organic leads for emerging and even infant litigations like this, It’s a good time to get into it. Not do not have to spend a lot of money on getting these cases. And and yeah, if you can file them and you can carry that kind of a small budget for this type of new litigation, I think is a good idea.
Liel: [00:33:57] All right. Let’s put let’s put Chad GPT here on the bench for a moment. I just typed in I have it here opened in front of me and I just typed in what is the Tylenol mass tort? And this is what it spit it out. Okay. The Tylenol mass tort refers to a series of lawsuits filed against the manufacturers of Tylenol in 90s 80s after several people died from taking cyanide laced capsules of the over-the-counter pain medication. The incident, which is now known as a Tylenol murderer’s Jesus, resulted in significant changes to the packaging and marketing of over-the-counter drugs in the United States. The lawsuits allege that the manufacturer has failed to adequately protect the public from the tampered products and sought damages for the harm caused by the poison Tylenol. You see you see why this is not going to work for you because this is giving you information about something that happened in the eighties. This is not now. This is not what we are talking about right now. So to new with precaution. Yeah. Proceed with caution. Right. Proceed with caution. It’s good. It’s fun. It’s really mind blowing. Right. It tells you this. And by the way, I do want to point out those who were in. In the first Tylenol mass tort back in the eighties, because I did learn that apparently Tylenol is not being. It’s not a stranger to the master tort, to the mass tort world. I got to give a hot slap to the people that came up with the Tylenol murderers as a tagline for the. Yeah. Great, great, great way of positioning. Great way of positioning the case in the public opinion. All right. So, Grace, thank you so much. What a great opportunity to catch up with you again. And I’m going to be looking forward to our next one, which is going to be hopefully in a few weeks from now. Awesome. Oh, no. I’ll see you. We’re going to.
Grace: [00:35:43] See you next.
Liel: [00:35:44] Week. Right. But conversation wise, in this context, yeah, it’s going to be a little while, but thank you. Thank you for listening. And yeah, we’ll be back soon.
Grace: [00:35:52] See you soon, Liel.
Liel: [00:35:53] All right, Bye. If you like our show, make sure you subscribe. Your coworkers leave us a review and send us your questions at: ask@incamerapodcast.com. We’ll see you next week.
Leave a Reply
Your email address will not be published. Required fields are marked *